- Report
- September 2021
- 25 Pages
Russia
From €825EUR$966USD£727GBP
- Report
- July 2024
- 280 Pages
Global
From €1700EUR$1,859USD£1,447GBP
€2428EUR$2,655USD£2,067GBP
- Report
- April 2024
- 280 Pages
Global
From €2286EUR$2,499USD£1,946GBP
€3265EUR$3,570USD£2,779GBP
- Report
- March 2023
- 300 Pages
Global
From €2286EUR$2,499USD£1,946GBP
€3265EUR$3,570USD£2,779GBP
- Report
- November 2022
- 275 Pages
Global
From €2286EUR$2,499USD£1,946GBP
€3265EUR$3,570USD£2,779GBP
- Report
- October 2022
- 270 Pages
Global
From €2286EUR$2,499USD£1,946GBP
€3265EUR$3,570USD£2,779GBP
- Report
- October 2022
- 281 Pages
Global
From €2286EUR$2,499USD£1,946GBP
€3265EUR$3,570USD£2,779GBP
- Report
- September 2022
- 251 Pages
Global
From €2286EUR$2,499USD£1,946GBP
€3265EUR$3,570USD£2,779GBP
- Report
- September 2022
- 242 Pages
Global
From €2286EUR$2,499USD£1,946GBP
€3265EUR$3,570USD£2,779GBP
- Report
- September 2022
- 293 Pages
Global
From €2286EUR$2,499USD£1,946GBP
€3265EUR$3,570USD£2,779GBP
- Report
- August 2022
- 321 Pages
Global
From €2286EUR$2,499USD£1,946GBP
€3265EUR$3,570USD£2,779GBP
- Report
- August 2022
- 385 Pages
Global
From €2458EUR$2,688USD£2,093GBP
€3512EUR$3,840USD£2,990GBP
- Report
- May 2022
- 220 Pages
Global
From €2213EUR$2,419USD£1,883GBP
€3161EUR$3,456USD£2,691GBP
- Report
- January 2022
- 262 Pages
Global
From €2376EUR$2,598USD£2,023GBP
€3395EUR$3,712USD£2,890GBP
- Report
- January 2022
- 210 Pages
Global
From €2376EUR$2,598USD£2,023GBP
€3395EUR$3,712USD£2,890GBP
- Report
- January 2022
- 168 Pages
Global
From €2376EUR$2,598USD£2,023GBP
€3395EUR$3,712USD£2,890GBP
- Book
- November 2022
- 352 Pages
- Book
- March 2025
North America
- Book
- October 2023
North America

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more